Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Steven Maron, MD, MSc Given the recent identification of actionable biomarkers like PD-L1 and MSI-H,1-3 it’s important to test patients with gastroesophageal cancer for these biomarkers as they may provide insights into options for a patient’s treatment plan.4,5 To learn more about how we can detect b…

What turns trauma into posttraumatic stress disorder (PTSD)? Credit available for this activity expires: 11/21/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001948?ecd=bdc_podcast_libsyn_mscpedu

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sarah Shizuko Morimoto, PsyD Digital therapeutics are a rapidly developing type of treatment option across several therapeutic areas, including mental health. And while the technology is advancing rapidly, the science behind it needs time to catch up, so it’s important to evaluate the supporting evide…

Dr Tanios Bekaii-Saab from Mayo Clinic in Phoenix, Arizona, and Dr Philip A Philip from the Henry Ford Cancer Institute in Detroit, Michigan, discuss recent research presentations on the treatment of gastrointestinal cancers.By Neil Love, MD

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Robert McCarron, MD Guest: Arwen Podesta, MD Digital therapeutics are a relatively new and intriguing treatment option in mental health care but translating them from a clinical trial to clinical practice can be challenging. That’s why Drs. Robert McCarron and Arwen Podesta join Dr. Charles Turck to s…

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Maggie Emerson, DNP, APRN, PMHNP-BC Guiding patients and caregivers through the fast-moving landscape of digital therapeutics can be a challenging but worthwhile part of providing effective and accessible care. That’s why Dr. Charles Turck speaks with Dr. Maggie Emerson about partnering with patients …

Did you know agitation is a treatable entity among patients with Alzheimer’s disease? Learn about potential causes and treatments for agitation. Credit available for this activity expires: 10/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/back-basics-agitation-associated-alzheimers-disease-2024a1000jlr?e…

Top tips for informed conversations with patients and their families around this new class of drugs for Alzheimer’s disease (AD). Credit available for this activity expires: 10/28/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001764?ecd=bdc_podcast_libsyn_mscpedu…

How to diagnose and manage gastroesophageal reflux disease (GERD) in the primary care setting. Credit available for this activity expires: 10/24/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001780?ecd=bdc_podcast_libsyn_mscpedu

Guest: Jennifer L. Payne, MD Guest: Melissa Simon, MD Since postpartum depression is a serious medical condition that can negatively impact mothers, infants, and partners, it is important to identify symptoms in a timely manner.1-4 Dr. Jennifer Payne and Dr. Melissa Simon are here to share their clinical experiences screening patients for postpartu…

Host: Matt Birnholz, MD Guest: Jennifer L. Payne, MD Guest: Melissa Simon, MD Postpartum depression is a serious medical condition that is among the most common complications during and after pregnancy; however, it is often underdiagnosed.1-4 To learn more about screening patients for postpartum depression, Dr. Matt Birnholz speaks with Dr. Jennife…

In this episode, Caitlin Costello, MD, discusses important topics related to relapsed/refractory (R/R) multiple myeloma (MM), including: 3 bispecific antibodies approved for the treatment of R/R MM that target BCMA or GPRC5D The role of bispecific antibodies in R/R MM Safety considerations for patients while receiving a bispecific antibody Emerging…

Do you know the latest data on EGFR-mutated and ALK-positive non-small cell lung cancer (NSCLC)? Credit available for this activity expires: 10/16/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001752?ecd=bdc_podcast_libsyn_mscpedu

Dr Thierry Alcindor from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for desmoid tumors and review novel options for targeted therapy.By Neil Love, MD

In this episode, Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss important topics related to gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including: The diagnosis and typical presenting symptoms of GEP-NETs Findings from recent key phase III studies including NETTER-2 and CABINET Recommendations for treatment sequencing No…

In this episode, listen to Ana Oaknin, MD, PhD and Alexandra Leary, MD, PhD, share their clinical insights and takeaways on key updates and new data presented for ovarian, endometrial, and cervical cancer at the ESMO 2024 annual congress including: Phase III PRIMA/ENGOT-OV26/GOG-3012 Final OS Results: Niraparib as First-Line Maintenance in Advanced…

What’s changed in how we should manage resistant hypertension? Credit available for this activity expires: 9/30/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001663?ecd=bdc_podcast_libsyn_mscpedu

Lively Quickfire session on helping patients with cognitive and negative symptoms. Credit available for this activity expires: 9/30/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001571?ecd=bdc_podcast_libsyn_mscpedu

In this episode, listen to Matthew S. Davids, MD, MMSc​, and Lindsey Roeker, MD, discuss BTK inhibitor resistance and how it shapes treatment choices for patients with CLL, including: Contemporary treatment paradigms for patients with CLL Safety and efficacy of current regimens Molecular testing, including when and how to test for BTK inhibitor res…

In the face of the rising incidence of liver disease, how is your multidisciplinary team using imaging for surveillance and management of patients with hepatocellular carcinoma (HCC)? Credit available for this activity expires: 9/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001653?ecd=bdc_podcast_libs…

Do you know the best approaches to managing patients with endometrial cancer in the adjuvant setting? Credit available for this activity expires: 9/24/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001649?ecd=bdc_podcast_libsyn_mscpedu

Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco…

Do you know which type of biliary tract cancer (BTC) has the highest rate of HER2 aberrations? Credit available for this activity expires: 9/20/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001632?ecd=bdc_podcast_libsyn_mscpedu

Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.By Neil Love, MD

How does magnetic resonance imaging (MRI) play a role in identifying biomarkers for patients with steatotic liver disease? Credit available for this activity expires: 9/13/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001595?ecd=bdc_podcast_libsyn_mscpedu…

Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers.By Neil Love, MD

Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other sarcomas.By Neil Love, MD

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available and emerging clinical data for second-line and beyond treatments in patients with recurrent ROS1-altered advanced NSCLC including: Assessing ROS1-TKI resistance mutations with tumor and liquid biopsies in patients with ROS1-altered advan…

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available clinical data in support of frontline treatments for ROS1-altered NSCLC including: Efficacy and safety data for crizotinib, entrectinib, and repotrectinib in patients with ROS1-altered advanced NSCLC Long-term safety observations for cri…

What is processing speed? Does it matter? Learn why it absolutely does for your patients. Credit available for this activity expires: 8/3/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001439?ecd=bdc_podcast_libsyn_mscpedu

What's ready for prime time and what's in the pipeline in Alzheimer’s disease (AD) diagnosis and care? View conference highlights to find out. Credit available for this activity expires: 8/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001535?ecd=bdc_podcast_libsyn_mscpedu…

Delve into the impact of revolutionary multiplex testing for diagnosing pneumonia. Credit available for this activity expires: 8/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001528?ecd=bdc_podcast_libsyn_mscpedu

Recent advances in our understanding of immunoglobulin A (IgA) nephropathy (IgAN) have led to an abundance of research into new therapies; our experts will guide you through it all. Credit available for this activity expires: 8/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001534?ecd=bdc_podcast_libsyn…

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the current understanding of ROS1 rearrangements in non-small-cell lung cancer tumor biology and its implications for molecular testing and treatment selection including: ROS1-gene fusions in advanced lung cancer ROS1 testing recommendations with DNA …

Are your patients' kidneys fighting a silent battle? Our experts give insight on earlier detection of IgAN and react to a real patient's experience. Credit available for this activity expires: 8/23/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001513?ecd=bdc_podcast_libsyn_mscpedu…

Do you have the latest data on novel therapies for congenital adrenal hyperplasia (CAH)? An expert panel discusses. Credit available for this activity expires: 8/23/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001510?ecd=bdc_podcast_libsyn_mscpedu

Host: Jennifer Caudle, DO Guest: Samuel R. Wilson, MD Sickle cell disease is among the most common inherited conditions globally, affecting more than seven million individuals worldwide.1-3 Given its prevalence, it is important to understand all of the complexities surrounding this disease. Joining Dr. Jennifer Caudle to discuss the pathophysiology…

How much do you know about rapid molecular diagnostics for gastrointestinal (GI) infections? Credit available for this activity expires: 08/13/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001464?ecd=bdc_podcast_libsyn_mscpedu

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jessie Hsieh, MD Guest: David Isaacson, MD About 70 percent of all cancer-related deaths are associated with cancers that don't have recommended USPSTF screening modalities.1 But the good news is that adding multicancer early detection (MCED) testing to usual care screenings could help address this ga…

In this episode, listen to Floor J. Backes, MD, and Angeles Alvarez Secord, MD, MHSc, share their clinical insights and takeaways on new data presented for endometrial, ovarian, and cervical cancers presented at the 2024 annual meetings of the Society of Gynecologic Oncology and American Society of Clinical Oncology including: RUBY Part 1 Subgroup …

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Leigh Anne Cantrell, MD, MSPH The updated ASCCP guidelines now address the use of dual-stain technology for cervical cancer management. CINtec PLUS Cytology is a test for the co-expression of p16 and Ki67 and confirms the presence of a transforming HPV infection and defines patients with …

What do you do when your patients are unravelling due to their antidepressant? Credit available for this activity expires: 7/26/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001393?ecd=bdc_podcast_libsyn_mscpedu

Get the latest information on new lung cancer data from Chicago. Credit available for this activity expires: 7/22/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001363?ecd=bdc_podcast_libsyn_mscpedu

In this episode, Dr Virginia Kaklamani moderates a discussion with Dr Aditya Bardia and Dr Sarah Sammons answering audience questions on the latest data on the use of oral SERDs therapy, including how to incorporate this new class of therapy into treatment plans for patients with HR+/HER2- breast cancer. Presenters: Virginia Kaklamani, MD, DSc Prof…

In this podcast episode, Farrukh Awan, MD, Jeremy S. Abramson, MD, MMSc, and Shuo Ma, MD, PhD, discuss real-world patient cases and how to align current clinical practice with the NCCN guidelines for CLL/SLL, including: Prognostic variables when deciding between regimens Role of MRD in CLL Results from the phase II CAPTIVATE trial Choosing among th…

Dive into the fascinating world of immunoglobulin A nephropathy (IgAN), the most common form of primary glomerulonephritis worldwide. Credit available for this activity expires: 7/16/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001351?ecd=bdc_podcast_libsyn_mscpedu…

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer.By Neil Love, MD

Are you providing culturally competent care for your Hispanic patients? Credit available for this activity expires: 7/12/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001327?ecd=bdc_podcast_libsyn_mscpedu

In this episode, listen to Dr Brady L. Stein share his clinical insights and takeaways on new data for myeloproliferative neoplasms (MPNs) presented at the 2024 ASCO Annual Meeting and the EHA 2024 Congress including: Long-term survival adjusted for treatment crossover in patients with myelofibrosis (MF) treated with momelotinib vs danazol in the M…

In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including: Rationale for targeting CELMoDs in NHL Mechanism of action of CELMoDs Key studies and available efficacy and safety data with investigational CELMoDs in NHL Key ongoing clinical trials of CELMoDs in NHL Strategies to…